BVF as of Sept. 30, 2011
Portfolio Holdings for BVF
BVF holds 22 positions in its portfolio as reported in the September 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Rigel Pharmaceuticals | 21.1 | $50M | 6.8M | 7.36 | |
| Ligand Pharmaceuticals In (LGND) | 16.3 | $38M | 2.8M | 13.68 | |
| Neurocrine Biosciences (NBIX) | 13.4 | $32M | 5.3M | 5.98 | |
| Targacept | 9.8 | $23M | 1.5M | 15.00 | |
| Infinity Pharmaceuticals (INFIQ) | 7.5 | $18M | 2.5M | 7.05 | |
| Pharmacyclics | 5.8 | $14M | 1.2M | 11.83 | |
| ISIS Pharmaceuticals | 5.7 | $14M | 2.0M | 6.78 | |
| Array BioPharma | 4.3 | $10M | 5.2M | 1.95 | |
| Flamel Technologies | 3.5 | $8.4M | 2.0M | 4.17 | |
| Icagen (ICGN) | 2.7 | $6.3M | 1.1M | 5.98 | |
| Affymax (AFFY) | 2.0 | $4.8M | 1.1M | 4.48 | |
| Oncothyreon | 1.9 | $4.5M | 748k | 5.98 | |
| Nektar Therapeutics | 1.6 | $3.9M | 800k | 4.85 | |
| Myrexis (MYRX) | 0.9 | $2.0M | 745k | 2.74 | |
| Capstone Therapeutics | 0.8 | $1.9M | 7.8M | 0.25 | |
| Genvec | 0.8 | $1.8M | 609k | 2.89 | |
| Palatin Technologies | 0.7 | $1.7M | 3.4M | 0.51 | |
| NeurogesX | 0.5 | $1.1M | 1.2M | 0.89 | |
| Ironwood Pharmaceuticals (IRWD) | 0.4 | $934k | 87k | 10.80 | |
| Osteologix (OLGX) | 0.2 | $474k | 1.6M | 0.29 | |
| Cadus Corporation | 0.1 | $364k | 269k | 1.35 | |
| AutoImmune (AIMM) | 0.0 | $36k | 3.6M | 0.01 |
